Seifu DanielTefera Betelhem2018-06-272023-11-062018-06-272023-11-062015-06http://etd.aau.edu.et/handle/123456789/4149Background: Type 2 diabetes is a major non-communicable disease with an increasingprevalence in Ethiopia and worldwide. About 2% of Ethiopians are reported to have type 2diabetes, but this may be an underestimate, due to a paucity of studies on diabetes epidemiologyin Ethiopia. Objective: Assessment of insulin resistance and dyslipidemia in type 2 diabetic patientsattending diabetic clinic of the Tikur Anbessa Hospital, Addis Ababa. Methods: This study was carried out on 106 type 2 diabetic patients attending Tikur AnbessaSpecialized Hospital Diabetic Clinic. Fasting blood glucose, serum lipid panels, serum insulinconcentrations, Apo lipoprotein A-1 and Apo lipoprotein B were measured in diabetics who weretaking oral medications. Patients taking insulin were excluded from the study. Insulin resistancewas measured by calculating HOMA-IR for each patient. Blood pressure, body mass index(BMI), waist circumference and smoking status were also determined. Result: Most patients (80%) had poorly controlled fasting blood glucose (>126 mg/dL), andthis was similar for males and females. Serum triglycerides were abnormally high in 58.7% ofpatients, LDL-cholesterol levels were elevated above 100 mg/dL in 50% of patients, and serumHDL-c levels were abnormally low in 76.9 % of patients.88.6% of the diabetic patients hadshowed significant insulin resistance (P<0.05), indicated by an elevated HOMA-IR index (>3.0).Two third of the diabetic patients showed normal blood pressure. Furthermore, sixteen ofthe 106 patients were cigarette smokers and smokers over 40 years old with diabetes hadsubstantial cardiovascular risks as determined by their Framingham cardiovascular risk score. Conclusion: These results emphasize the need for improvedprograms for diabetes screening,prevention and care in Ethiopia. The biochemical and medical significance of the results arediscussed. Key words:Type2Diabetes,Insulin Resistance, Dyslipidemia, HOMA-IR, ApolipoprotineenType2Diabetes,Insulin Resistance Dysl ApolipoprotineInsulin Resistance and Dyslipidemia in Type 2Diabetic Patients: A Cross-Sectional Study at the Diabetic Clinic of Tikur Anbessa Specialized Teaching HospitalThesis